Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PTH(1-84) vs alendronate in postmenopausal osteoporosis
CTR20160847Phase 3Completed
- Sponsor
- Chongqing Kerun Biopharmaceutical
- Start
- Nov 2016
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of parathyroid hormone 1-84 in osteoporosis, sponsored by Chongqing Kerun Biopharmaceutical. Started Nov 2016; status: completed.
02
Drugs
parathyroid hormone 1-84
03
Conditions
osteoporosis
Beyond the preview
Go deeper on CTR20160847.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20160847.